Stock Picks
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maz,
I have no doubt that they will get conditional approval by Nasdaq within the next week. Conditional approval would be we approve you for uplist if you get share price to $2 or $3 or $4. Then they would be able to drop PRs left and right and get there with ease.
I don’t think they can buy during the NASDAQ quiet period or else I’m sure they would.
Nice post. Working with NFL on CTE! Damn. Too many big partnerships to count at this point.
Yes, it was gone all morning and back now. I guess the fake article written by shorts is technically a paid promo. (Paid for by shorts)
He may be talking about the “promo” symbol that was removed on OTC markets this morning. Meaning we are vetted and ready for takeoff!!!
Yes, everyone within company was vetted and approved by SEC via Form 10. So any bs allegations about a former manager doesn’t matter. SEC vetted and approved everyone within current management in early June. That’s what matters.
Yes, they are absolutely in trouble if it uplist next week. Pretty damn hard to cover millions of shares.
PRED promo symbol removed! Great news!
https://www.otcmarkets.com/stock/PRED/overview
Thanks for posting this Bear. According to this document it says not to exceed 45 calendar days. That puts us right at July 18th. Of course it could happen sooner.
This is exactly what institutions want the shorts to do. It’s almost like shorts are paving the road for them.
Shake the tree out, then uplisting next week and they go all in between $3-$5. Then bam, huge PRs get released driving price to $25 by end of August. Then huge revenue comes in driving price to $100 by end of 2020.
It’s almost too easy for them.
They turned down the $40 offer. They know it’s going much higher.
Yep, money about to flow in over the next 48 hours! Ya baby
Congrats to all the PRED longs! Gonna be an exciting week!!!
This is gonna be huge...
“Finally, we anticipate the release of their Endometriosis kit that could easily accelerate their revenue into the hundreds of millions of dollars within 6-18 months.”
LOL. They are trying to force panic selling before the uplist this week. Don’t fall for it.
LOL. They don’t have a working product or employees. It’s a shell ticker at the moment.
Yes, that’s a fact. They can short all they want, but hedge funds are waiting to buy once it’s uplisted and they have way more money than Canada Tommy.
Thanks BearNaked! This guy is trying desperately to discredit Nasdaq own timelines.
It will go to $7-$10 with uplist news this week. Lots of big boys waiting to get in. Then should have a long list of PRs about partnerships and revenue that should knock it to $30-$50 by Mid-August.
Ya, people seem to forget we have Dave Donohoe who spent 9 years with Nasdaq. We are golden. A few more days left! Can’t wait
Congrats to anyone picking up shares today. We are expecting a gap up on Monday and obviously a significant gap up on Wednesday. This will be the last chance to get in under $5.
They will get tons of buyout offers. Management is too smart to sell under $500.
My guess is they will make more aquistions...very good chance PRED spins out multiple divisions once they hit $100-$125 range next year.
LOL, your assuming they are still a functioning company. They literally don’t have a working product or any employees. So you can stop with the pump posts.
Nasdaq news can come whenever. PRED doesn’t have control over when Nasdaq uplist them. Even if the news comes out after hours today, it would still take a few business days before they were actually trading on Nasdaq.
We know that. Very good chance of after hours uplist news today or tomorrow morning! Great time to add shares of you have more powder.
Nice! This deal may be bigger than we all thought. Thermo is worldwide baby!
https://scr.zacks.com/News/Press-Releases/Press-Release-Details/2019/PRED-Thermo-Fisher-Deal-to-Advance-Endometriosis-Research/default.aspx
PRED: THERMO FISHER DEAL TO ADVANCE ENDOMETRIOSIS RESEARCH
06/28/2019
By John Vandermosten, CFA
OTC:PRED | NYSE:TMO
Over the last couple weeks Predictive Technology Group (OTC:PRED) has achieved two milestones in its advance towards validating and commercializing its endometriosis diagnostic test. On June 19th the company announced a research collaboration with Thermo Fisher Scientific (NYSE:TMO) and on June 24th presented new genetic findings in endometriosis at the European Society of Human Reproduction and Embryology (ESHRE) conference. We attach significant value to Predictive’s efforts in endometriosis as it is a component of the ARTguide and Fertility Dx diagnostics and is the purpose of the ENDORisk diagnostic. As we discussed in our initiation, the disease impacts an estimated 200 million women worldwide, is frequently misdiagnosed and can be diagnosed early with Predictive’s genetic tests.
Thermo Fisher’s collaboration with Predictive Laboratories is focused on studying the genetic factors underlying infertility in women. Thermo Fisher is a global leader in diagnostics and provides a number of assays and sequencing tools that are used in the development, optimization, validation and verification of tests for reproductive health. The primary focus of the work will center on endometriosis, which is estimated to affect 40% of women with infertility. With this arrangement, not only does Thermo Fisher help cement its reputation as a dominant player in the research of genetic diseases but Predictive is able to bring greater attention to its leading edge work. Predictive has combined the information from its DNA sample library, exome sequencing database, ancestry records and other genetic data with Thermo Fisher’s assays and sequencers to develop effective tests to estimate the probability of certain conditions.
View Exhibit I - ARTguide Diagnostic Result Tear Sheet
The collaboration will combine Predictive’s research with Thermo Fisher’s equipment to identify women who are most likely to suffer from endometriosis. The equipment that will be used includes Thermo Fisher’s Applied Biosystems CarrierScan Assay, Ion ReproSeq PGS Assay, CytoScan Dx Assay, and Ion AmpliSeq Exome RDY.
View Exhibit II - Applied Biosystems CarrierScan Assay Components
Many of these assays and tests can be run on the Ion GeneStudio S5 genetic sequencer imaged below.
View Exhibit III - Ion GeneStudio S5 System
As part of Predictive’s research advancements in identifying gene markers for disease, Dr. Kenneth Ward takes on a leading role. He sits on Predictive’s Scientific Advisory Board and also presented new data demonstrating the genetic basis of endometriosis at the ESHRE conference held June 23 to 26 in Vienna, Austria. His work condensed the key identifiers of endometriosis to mutations in four genes identified as ZNF586, LUZP4, POP4 and UNC5CL.
The underlying research found that 25% of women with endometriosis present at least one of these mutated genes compared to 8% for the population overall. It additionally found that there were 141 distinct coding mutations in the identified genes. These results combined with other genetic data will be used to develop genetic tests that will predict the likelihood of endometriosis in women. The process also forms the basis for an approach that will support the development of additional tests in scoliosis, degenerative disc disease and other genetic disorders.
Predictive has distinguished itself as a trailblazer in genetic diagnostic testing. Their access to a substantial and broad genetic data set and consistent focus on fertility medicine has placed them in the vanguard of companies in their industry. We expect to see additional genetic tests launched in the coming quarters leveraging the company’s data and research expertise.
Form 10 was already accepted bud. They skipped those lower exchanges and went right to Nasdaq. When you have a worldwide company this big with so many big pharma partners, you can do that.
No
The company is based in Salt Lake City. Looks like the IR company is in Los Angeles.
Hopefully Nasdaq uplist news hits after hours today. We should see a nice gap up in the morning if all goes right.
Hey DJS1!!! Glad you’re here. This one is about to run. Then you’re other ticker may take off soon after.
Did your analysis account for all the news they are about to come out with after uplisting? Please post a screen shot of your short position, so we can all laugh at you when it goes over $20 next month.
It could be 2 days or 2 weeks or 2 months til Nasdaq. No one really knows. IR claims everything is still on target for uplist any day.
Nice try, no one in their right mind would sell those until after Nasdaq uplisting and the big announcements with Big Pharma come out.
PRED can’t release juicy PRs involving partnerships involving money yet, because if they did they would have to resubmit financials on their Nasdaq application.
Once they get the NASDAQ uplisting, then they are open to release any PRs involving new revenue or cash deals with big pharma.
Of course it will be, but with debt crisis hitting in 2020 it could dip to $75 first, then up to $300 by 2025.
Someone made a new one. Weird that they couldn’t use the old twitter account. Hmmmmm
Interesting that the twitter account had multiple tweets one day when all the pumpers were here and has never had another tweet since then. Makes you wonder who really owns it or what the intentions were???
Interesting. Sounds like they are getting ready for the big hedge funds to enter!
$25 Billion in yearly revenue. Market cap is $117 Billion. Call it whatever you want, it’s a huge company to partner up with.